Dear Colleague Letter: DTBE Acting Director
NCHHSTP Leadership Announcement
August 2, 2013
As we have previously announced, RADM Kenneth G. Castro, MD, Assistant Surgeon General, Director, Division of Tuberculosis Elimination (DTBE), has agreed to serve as Acting Director of the Division of HIV/AIDS Prevention (DHAP) beginning August 19, 2013. We plan to move forward rapidly to identify the next permanent Director of DHAP and hope to post the position very soon.
In the interim, we are pleased to announce that Dr. Philip LoBue has agreed to serve as Acting Director of DTBE. Dr. LoBue received his undergraduate and medical degrees from the University of Pennsylvania. He received postgraduate training in Internal Medicine and Pulmonary and Critical Care Medicine at the University of California San Diego Medical Center where he was subsequently a Clinical Instructor and Assistant Clinical Professor of Medicine from 1995 to 1999. In 1999, Dr. LoBue joined DTBE as a medical epidemiologist assigned to the Tuberculosis Control Program in San Diego County, CA. In 2004, he moved to CDC headquarters in Atlanta, GA, to become Chief of the Medical Consultation Team of DTBE. In 2006, Dr. LoBue was appointed to his current position as Associate Director for Science, DTBE. His primary duties include oversight of all scientific activities of DTBE, including two national and international research consortia conducting clinical trials and epidemiologic studies.
Dr. LoBue is a fellow in the American College of Physicians and American College of Chest Physicians. He is also a member of the American Thoracic Society (ATS), in which he has served on the Ethics and Conflict of Interest Committee and the Program (chair 2008-2009), Planning, and Executive Committees of the Microbiology, Tuberculosis, and Pulmonary Infections Assembly. Dr. LoBue has authored or co-authored more the 60 publications including peer-reviewed journal articles, book chapters, and Morbidity and Mortality Weekly Report articles. He has chaired or served on more than 10 guidelines and recommendations committees and panels for multiple organizations including CDC, ATS, the US Federal Tuberculosis Task Force, and the World Health Organization. His scholarly interests include tuberculosis diagnosis, treatment, and transmission dynamics, evidence-based guideline development, and human subjects research ethics.
We thank Dr. LoBue for his willingness to serve as Acting Director of DTBE.
Jonathan H. Mermin, M.D., M.P.H.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
- Page last reviewed: August 5, 2013
- Page last updated: February 24, 2014
- Content source: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention